Skip to main content
Filing year 2024

Innovation to End Neglected Diseases

East Palo Alto, California·EIN 47-1056489·NTEE H99 · Medical Research·501(c)(3)
Total revenue
$346k
Total assets
$0
Total expenses
$346k
Reported officers
3
Mission

Our mission is to develop and ensure accessibility of safe and effective new medicines and diagnostics for infectious diseases that disproportionately affect people of the developing world. We inspired individuals who are committed to changing the way diseases are treated in the developing world.

Reported officers (all unpaid)

No paid executives reported in 2024. Innovation to End Neglected Diseases reported 3 unpaid officers and board members on its 990.

President
Secretary
Treasurer
Sector benchmark

What Medical Research executives earn in California

Innovation to End Neglected Diseases reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization in California earns a median of $129,149.

25th percentile
$60k
Median
$129,149
75th percentile
$297k
90th percentile
$602k

These are medical research sector-wide figures, not this organization's reported pay. Based on 153 organizations across 153 filings (2022 – 2024).

See full Medical Research pay data for California
FAQ

Common questions about Innovation to End Neglected Diseases

What are Innovation to End Neglected Diseases's revenue and expenses?

In 2024, Innovation to End Neglected Diseases reported $346k in total revenue and $346k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.